A STAT Investigation

A STAT Investigation Nicholas Florko

With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem

A STAT Investigation Nicholas Florko and Elissa Welle

The FDA stands by as the vaping industry flouts its orders

A STAT Investigation Tara Bannow

STAT Plus: The private equity firms, like Blackstone and KKR, behind 8 of the biggest names in autism therapy

A STAT Investigation Tara Bannow

Parents and clinicians say private equity’s profit fixation is short-changing kids with autism

A STAT Investigation Allison DeAngelis, Adam Feuerstein, and Jason Mast

STAT Plus: At pioneering center for gene therapy, Jim Wilson presided over toxic, abusive workplace, staffers say

A STAT Investigation Jared Whitlock

Nursing home chain’s tangled corporate structure and bankruptcy threats stymied litigation

A STAT Investigation Casey Ross

STAT Plus: Internal documents show privacy lapses at a data powerhouse that holds health records and consumer information on millions of Americans

A STAT Investigation Olivia Goldhill

Encouraged by right-wing doctor groups, desperate patients turn to ivermectin for long Covid

A STAT Investigation Katie Palmer

STAT Plus: Cue Health rode Covid-19 to an NBA deal and a $3 billion valuation. Now it faces layoffs and a rocky future

A STAT Investigation Usha Lee McFarling

What will it take to level the playing field for Black residents?

A STAT Investigation Usha Lee McFarling

‘It was stolen from me’: Black doctors are forced out of training programs at far higher rates than white residents

A STAT Investigation Casey Ross

STAT Plus: How a complex web of businesses turned private health records from GE into a lucrative portrait of patients

A STAT Investigation Olivia Goldhill

A psychedelic therapist allegedly took millions from a Holocaust survivor, highlighting worries about elders taking hallucinogens

A STAT Investigation Katie Palmer and Mario Aguilar

STAT Plus: FDA’s breakthrough device program, meant to benefit patients, is delivering the biggest gains for companies

A STAT Investigation Casey Ross

STAT Plus: AI gone astray: How subtle shifts in patient data send popular algorithms reeling, undermining patient safety

A STAT Investigation Hyacinth Empinado and Usha Lee McFarling

Watch: A rebel with a cause: As a mentor and a leader, this Black orthopedic surgeon fights to diversify his field

A STAT Investigation Usha Lee McFarling

Orthopedic surgeons pride themselves on fixing things. Can they fix their own field’s lack of diversity?

A STAT Investigation Usha Lee McFarling

The whitest specialty: As medicine strives to close its diversity gaps, one field remains a stubborn outlier

A STAT Investigation Rachel Cohrs Zhang

STAT Plus: How America’s largest Catholic hospital system is moonlighting as a private equity firm

A STAT Investigation Eric Boodman

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?

A STAT Investigation Megan Molteni and Mario Aguilar

STAT Plus: Inside the downfall of longevity crusader Aubrey de Grey — and the cult of personality that concealed a pattern of harassment

A STAT Investigation Casey Ross

STAT Plus: Epic’s sepsis algorithm is going off the rails in the real world. The use of these variables may explain why

A STAT Investigation Usha Lee McFarling

‘Health equity tourists’: How white scholars are colonizing research on health disparities

A STAT Investigation Casey Ross

STAT Plus: Epic’s AI algorithms, shielded from scrutiny by a corporate firewall, are delivering inaccurate information on seriously ill patients

A STAT Investigation Olivia Goldhill

STAT Plus: ‘In their own bubble’: How a cancer center promoted an exclusive experimental drug to attract patients

A STAT Investigation Eric Boodman

Cement Head’s last fight: He was denied parole six times — until he was about to become a Covid-19 statistic

A STAT Investigation Casey Ross and Mario Aguilar

STAT Plus: Inside the fall of Watson Health: How IBM’s audacious plan to ‘change the face of health care’ with AI fell apart

A STAT Investigation Casey Ross

STAT Plus: Could AI tools for breast cancer worsen disparities? Patchy public data in FDA filings fuel concern

A STAT Investigation Casey Ross

STAT Plus: As the FDA clears a flood of AI tools, missing data raise troubling questions on safety and fairness